Sana Biotechnology Stock Quote SANA - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

4.75

Bid

4.75

Ask

5.40

Volume

1,112,531

4.735 Day's Range 5.04

2.745 52 Week Range 12.00

Market Cap

1.057B

Previous Close

4.90

Open

4.95

Last Trade

100

4.75

(formt)

Last Trade Time

16:20:02

Financial Volume

$ 5,361,390

VWAP

4.8191

Average Volume (3m)

1,808,609

Shares Outstanding

222,465,934

Dividend Yield

PE Ratio

-3.74

Earnings Per Share (EPS)

-1.27

Revenue

Net Profit

-283.26M

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring tec... Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.sana.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Sana Biotechnology Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SANA. The last closing price for Sana Biotechnology was $4.90. Over the last year, Sana Biotechnology shares have traded in a share price range of $ 2.745 to $ 12.00.

Sana Biotechnology currently has 222,465,934 shares outstanding. The market capitalization of Sana Biotechnology is $1.09 billion. Sana Biotechnology has a price to earnings ratio (PE ratio) of -3.74.

Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glia

Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice Additional proof-of-concept for the advancement of SC379, Sana’s...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.38	-7.40740740741	5.13	5.52	4.595	1481576	4.81637429	CS
4	-1.8	-27.4809160305	6.55	6.63	4.401	1486588	5.54290913	CS
12	-3.76	-44.1833137485	8.51	8.51	4.401	1808609	6.07361732	CS
26	-1.64	-25.6651017214	6.39	12	4.401	1903815	7.72538935	CS
52	-0.56	-10.5461393597	5.31	12	2.745	2008320	6.42075916	CS
156	-15.59	-76.6470009833	20.34	26.6	2.745	1445234	7.43088825	CS
260	-33.15	-87.4670184697	37.9	44.6	2.745	1307049	8.55316127	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VSMEVS Media Holdings Ltd	$ 1.26 (73.34%)	4.78M
SPRCSciSparc Ltd	$ 0.442 (37.22%)	1.09M
ARAYAccuray Incorporated	$ 1.83 (27.97%)	170.78k
AIFFFirefly Neuroscience Inc	$ 7.68 (20.94%)	1.6k
VEROVenus Concept Inc	$ 0.7002 (15.54%)	331.28k
TSBXTurnstone Biologics Corporation	$ 1.41 (-35.32%)	883.71k
TITNTitan Machinery Inc	$ 12.10 (-21.28%)	74.83k
VUZIVuzix Corporation	$ 0.7805 (-17.84%)	98.33k
TCBPTC BioPharm Holdings PLC	$ 2.90 (-12.91%)	1.02k
HWHHWH International Inc	$ 0.47 (-12.80%)	9.51k
XPONExpion360 Inc	$ 0.0904 (6.86%)	19.48M
VSMEVS Media Holdings Ltd	$ 1.26 (73.34%)	4.78M
NVDANVIDIA Corporation	$ 117.7799 (-0.25%)	4.37M
CSCOCisco Systems Inc	$ 48.15 (5.96%)	4.09M
IGIBiShares Trust iShares 5 to 10 Year Investment Grade Corp Bond	$ 52.95 (0.00%)	2.56M